Aeterna preclinical data

AEL announced preclinical findings that Neovastat reduced lung metastases by 70 percent when given

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE